Rabbit Polyclonal EIF3D antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 11 publications. Immunogen corresponding to Recombinant Fragment Protein within Human EIF3D aa 200-550.
View Alternative Names
EIF3S7, EIF3D, Eukaryotic translation initiation factor 3 subunit D, eIF3d, Eukaryotic translation initiation factor 3 subunit 7, eIF-3-zeta, eIF3 p66
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF3D antibody (AB155419)
Immunohistochemical analysis of paraffin embedded HUH7 xenograft labeling EIF3D with ab155419 antibody at 1/100.
- WB
Unknown
Western blot - Anti-EIF3D antibody (AB155419)
7.5 % SDS-PAGE
All lanes:
Western blot - Anti-EIF3D antibody (ab155419) at 1/3000 dilution
Lane 1:
PC12 whole cell lysate at 30 µg
Lane 2:
Rat2 whole cell lysate at 30 µg
Predicted band size: 64 kDa
false
- WB
Unknown
Western blot - Anti-EIF3D antibody (AB155419)
7.5 % SDS-PAGE
All lanes:
Western blot - Anti-EIF3D antibody (ab155419) at 1/5000 dilution
All lanes:
Mouse liver whole cell lysate at 50 µg
Predicted band size: 64 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF3D integrates into the large EIF3 complex which consists of multiple subunits and is vital for the proper assembly of the 40S ribosomal subunit. This assembly process is essential for the initiation of translation acting as a scaffold for other initiation factors. EIF3D contributes to the stabilization and binding of mRNAs to the ribosome facilitating efficient translation initiation. The protein is integral for mRNA selection and because of its interaction within the complex it influences cellular proliferation and growth.
Pathways
EIF3D participates actively in translation initiation and mRNA surveillance pathways. These pathways regulate gene expression at the translational level maintaining the fidelity and quality control of protein synthesis. EIF3D works closely with EIF3E another subunit within the EIF3 complex to modulate these processes. Their interaction ensures the correct binding of mRNA and aids in the prevention of errors during protein synthesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Science advances 10:eadl5638 PubMed39018414
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical laboratory analysis 37:e24825 PubMed36592991
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:1952-1961 PubMed35104170
2022
Applications
IHC-P, WB
Species
Human, Human
Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33568529
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 17:167 PubMed31118081
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 9:539-544 PubMed29123423
2017
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 6:1201-1210 PubMed28203520
2016
Applications
IHC, WB
Species
Unspecified reactive species, Unspecified reactive species
International journal of oncology 48:2580-90 PubMed27035563
2016
Applications
Unspecified application
Species
Unspecified reactive species
RNA biology 14:553-567 PubMed26828225
2016
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 86:715-22 PubMed25682860
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com